EPZ-719

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameEPZ-719
Drug Alias NameEPZ-719
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase SETD2 inhibitors
TargetsHistone-lysine N-methyltransferase SETD2
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEpizyme Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpizyme Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A